Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases

Area of Science:

• Cardiovascular Medicine
• Nanotechnology
• Immunology

Background:

• Cardiovascular diseases and comorbidities are rising, necessitating novel therapeutic strategies.
• Monocytes play a key role in various diseases and are potential therapeutic targets.
• Existing treatments often lack efficacy for complex comorbid conditions.

Purpose of the Study:

• To review the role of monocytes in cardiovascular diseases.
• To highlight nanoparticle-based monocyte targeting strategies.
• To explore therapeutic potential for comorbid conditions like diabetes, atherosclerosis, and HIV.

Main Methods:

• Literature review focusing on monocyte function in cardiovascular pathology.
• Analysis of current trends in nanoparticle drug delivery systems targeting monocytes.
• Examination of studies investigating nanoparticle-monocyte interactions in disease models.

Main Results:

• Monocytes are central players in the pathogenesis of diabetes, atherosclerosis, and HIV-related cardiovascular complications.
• Nanoparticle-based strategies show potential for targeted delivery to monocytes.
• Synergistic therapeutic approaches leveraging monocyte targeting are emerging.

Conclusions:

• Targeting monocytes with nanoparticles presents a viable strategy for managing cardiovascular diseases and their comorbidities.
• Further research into nanoparticle design and clinical application is warranted.
• This approach may offer improved treatment outcomes for patients with complex health profiles.